Allergy Therapeutics PLC
AGY
Company Profile
Business description
Allergy Therapeutics PLC is active in the healthcare sector in the United Kingdom. It is a pharmaceutical company mainly engaged in the treatment and prevention of allergies with aluminum-free products. The company's geographical segment includes Central Europe; Southern Europe and the Rest of the World. It generates maximum revenue from Central Europe which includes Germany, Austria, Netherlands, and Switzerland.
Contact
Dominion Way
WorthingWest SussexBN14 8SA
GBRT: +44 1903844700
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
30 June 2026
Employees
602
Stocks News & Analysis
stocks
Fair value downgraded for ASX heavyweight
Our capital allocation rating was also lowered due to balance sheet weakness.
stocks
ChatGPT enters the retail space and one company surges
Investors cheer the ability to purchase directly from ChatGPT.
stocks
Alibaba fair value increases by 49%
Stronger-than-expected AI demand internationally and domestically.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,122.00 | 0.50 | 0.01% |
CAC 40 | 7,895.94 | 15.07 | 0.19% |
DAX 40 | 23,880.72 | 135.66 | 0.57% |
Dow JONES (US) | 46,397.89 | 81.82 | 0.18% |
FTSE 100 | 9,350.43 | 50.59 | 0.54% |
HKSE | 26,855.56 | 232.68 | 0.87% |
NASDAQ | 22,660.01 | 68.86 | 0.30% |
Nikkei 225 | 44,544.19 | 388.44 | -0.86% |
NZX 50 Index | 13,433.99 | 141.63 | 1.07% |
S&P 500 | 6,688.46 | 27.25 | 0.41% |
S&P/ASX 200 | 8,831.20 | 2.20 | -0.02% |
SSE Composite Index | 3,882.78 | 20.25 | 0.52% |